Speaker(s): 

John Horne, MD, Resident, Geisinger - has nothing to disclose.

Sara Waqar, MD, Resident, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Distinguish hypertrophic LS from classic LS and dVIN using key histologic and immunophenotypic features.
• Recognize hypertrophic LS as a potential precursor lesion in the HPV-independent pathway to vulvar SCC.
• Evaluate whether platelet shortages lead to significant impacts on patient care outcomes.
• Explore whether guideline-concordant care for platelet transfusions may reduce waste while maintaining quality.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Zachary Hoffer, MD PhD and Jeffrey Prichard, DO have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.